Jan 30 (Reuters) - Eurofins Scientific SE EUFI.PA :
* EUROFINS ACHIEVES NEW RECORD LEVEL OF ANNUAL REVENUES
WHILE
DEMONSTRATING A STRONG INCREASE IN MARGINS AND CASH GENERATION
AND RETURNS TO ITS PRE-COVID PROFITABILITY AND CASH FLOW GROWTH
TRENDS
* EUROFINS CONFIRMS ITS LONG-TERM AVERAGE ORGANIC GROWTH
OBJECTIVE
OF 6.5% P.A.
* ADJUSTED EBITDA MARGIN OBJECTIVE FOR FY 2027 REMAINS 24%
AND
OBJECTIVE FOR SDI2 AT EBITDA3 LEVEL REMAINS ABOUT 0.5% OF
REVENUES IN FY 2027
* FY FCFF BEFORE DISCRETIONARY INVESTMENT IN OWNED SITES
REACHING
EUR 954M
* TARGETS TO MAINTAIN A FINANCIAL LEVERAGE IN RANGE OF
1.5-2.5X IN
MID-TERM AND INTENDS TO GRADUALLY BRING IT DOWN TOWARDS LOWER
END OF RANGE BY FY 2027
* BOARD OF DIRECTORS INTENDS TO PROPOSE AN ANNUAL DIVIDEND
OF EUR
0.60 PER SHARE
* OUTLOOK 2025: TARGETS MID-SINGLE-DIGIT ORGANIC GROWTH
* OUTLOOK 2025: POTENTIAL AVERAGE REVENUES FROM ACQUISITIONS
OF
EUR 250M, CONSOLIDATED AT MID-YEAR
* OUTLOOK 2025: ADJUSTED EBITDA MARGIN IS TO IMPROVE ABOVE
LEVEL
IN FY 2024 OF 22.3%
* OUTLOOK 2025: FCFF BEFORE INVESTMENT IN OWNED SITES WILL
IMPROVE
OVER LEVEL IN FY 2024
* PROGRESSION ON MARGIN AND CASH FLOW IS LIKELY TO BE
STRONGER IN
H2 2025 VERSUS H1 2025
* OBJECTIVE FOR CASH CONVERSION IN FY 2027 REMAINS ABOVE 50%
* IT IS OUR BASE ASSUMPTION THAT SOME END MARKETS WILL STAY
SUBDUED IN NEAR TERM
Source text: ID:nBw5sbXvGa
Further company coverage: EUFI.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))